Arteriovenous FistulaNCT01512927
Electro Stethoscope in Detect Arteriovenous Fistula (AVF) Stenosis
An observational study of Arteriovenous Fistula, run by National Taiwan University Hospital at 1 site in Taiwan.
Trial summary
The incidence and prevalence of end-stage renal disease (ESRD) in Taiwan are both the highest worldwide from 2001 to 2008. In Taiwan, more than 90% of the ESRD patients are hemodialysis patients. Read more about this study
- Who is it for?
- Ages 20 to 90 years
- Conditions the study is for
- Arteriovenous Fistula
- How many people
- 150 participants
- Where
- 1 siteTaiwan
- Study dates
- Jan 2012to Dec 2012
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 90 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: 150
Who may be able to join
- Age is more than 20 year-old.
- End-stage renal disease with regular hemodialysis for more than one year
Who cannot join
- 1. AVF/ AV graft is not located in upper arm.
Trial locations and contacts
1 site in 1 country.
DONG-FENG YEIH, Ph.D. contact
Taiwan1 site, 1 recruiting
- Recruiting
National Taiwan University Hospital
Taipei, Taiwan, 100
DONG-FENG YEIH, OPh.D., 886-2-23123456 ext. 63738, 601126@ntuh.gov.tw
DONG-FENG YEIH, Ph.D.
About this study
Official title: Electronic Stethoscope and Computer-aided Diagnostic System in Detecting Arteriovenous Fistula (AVF) Stenosis
The incidence and prevalence of end-stage renal disease (ESRD) in Taiwan are both the highest worldwide from 2001 to 2008. In Taiwan, more than 90% of the ESRD patients are hemodialysis patients. Either arteriovenous fistula (AVF) or arteriovenous graft (AV graft) is essential for the vascular access of these patients. However, frequent AVF stenosis or thrombosis occurs in 10-30% hemodialytic patients, and the rates are even higher, around 30-70%, in those who has a past history of AVF/AV graft stenosis. Therefore, early detection of AVF stenosis is essential in caring for these hemodialysis patients in terms of medical economics and psychological impact. Unfortunately, angiographic study is expensive and invasive and needs contrast medium injection. The diagnostic accuracy of color duplex ultrasound in AVF stenosis remains satisfactory, but it is not always available when decreased AVF flow or an acute thrombotic event occurs. Continuous AVF/ AV graft flow monitoring by patient himself is a better option in terms of long-term care. Previous study indicated that stethoscope waveform analysis could be used as an alternative to diagnosis of vascular stenosis. Therefore, we aim to investigate AVF/ AV graft stenosis by using the electronic stethoscope (3M Littmann) for AVF sound recording, followed by software analysis by using waveform decomposition, principle component analysis (PCA) and sequential forward selection algorithm [xx]. Our study results will provide a new diagnostic option, which is low cost, non-invasive and self-monitoring, of AVF stenosis in ESRD patients.
Read the detailed description
Hemodialysis is a well-established method for removal of fluid and uremic toxins and prolonging survival in patients with end-stage renal disease (ESRD). The most common permanent vascular assesses are autogenous and non-autogenous arteriovenous (AV) fistula, referred as AV fistula and AV graft, respectively. In Taiwan, both incidence and prevalence of ESRD remain highest worldwide. However, frequent vascular stenosis/ thrombosis events occurred because of repeated needle punctures. These will exert a large economic burden to our society and psychological impacts on ESRD patients [1]. Therefore, it is essential to develop an easy and patient-centered method to monitor the flow status in either AV fistula or AV graft.
Physical examination and auscultation are simple monitoring methods to assess the vascular access. There were several signs reported to be associated vascular stenosis, such as prolonged bleeding, arm edema, and changes in pulse characteristics of the vascular access, but they need a high level of skill and experience from the operator, such as doctors and nurses [2].
Unfortunately, angiographic study is expensive and invasive and needs contrast medium injection. The diagnostic accuracy of color duplex ultrasound in AVF stenosis remains satisfactory, but it is not always available when decreased AVF flow or an acute thrombotic event occurs. Continuous AVF/ AV graft flow monitoring by patient himself is a better option in terms of long-term care. Previous study indicated that stethoscope waveform analysis could be used as an alternative to diagnosis of vascular stenosis. Previous acoustic studies indicated that increased sound intensity, extra sounds, and higher spectral energy infrequency domain, ranging between 300 Hz and 1000 Hz. These findings are associated with the change from laminar flow to turbulent flow downstream the site of vascular stenosis [3]. In addition, phonoangiography studies pointed out that the systolic peak of stenotic segment is higher and narrower in the time domain compared to non-stenotic segment Methods: This is an observational cohort study. We plan to recruit 150 eligible patients with ESRD under regular hemodialysis for at least one year in national Taiwan University Hospital.
- Data gathering A. The first group of patients (study group) will be recruited from hose referred to endovascular intervention, e.g. angioplasty, due to vascular access dysfunction (n=30). An electronic stethoscope (3M-Littmann) will be used to record digital sound signals at 5 points with 30 seconds each, including AV junction, proximal and distal to both needle puncture sites, respectively. All data will be transferred to a computer for further anlaysis.
- The second group (validation cohort) will be recruited from patients with regular hemodialysis (HD) and received angioplasty at National Taiwan University Hospital (n=120). Those patients who received angioplasty for AVF or AV graft stenosis will also received follow-up angiography 12 weeks after angioplasty. We will record digital AVF/AV graft sound signals as mentioned above. In addition, blood pressure and AVF/AVG venous pressure, heart rate will be recorded. Diameter stenosis of restenotic segment will also be recorded and a diameter stenosis of 50% is regarded as significant.
- Post-processing The proposed method is based on the analysis of the envelope of the sound signals. Before, calculating the envelope, all signals will be down-sampled to 2k Hz, followed by a linear-phase, finite impulse response low-pass filter. PCA will then be applied to analysis as described previously [1-4]. PCA (principal components analysis)
- Analysis Sensitivity, specificity and diagnostic accuracy will be calculated based on each diagnostic criteria or basal function. Area under ROC curve will be calculated based on each diagnostic criteria derived from PCA method.
- Conditions
- Arteriovenous Fistula
- Keywords
- electronic stethoscope, arteriovenous fistula, hemodialysis,
- Medical subject headings
- Arteriovenous Fistula
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| ESRD with regular hemodialysis | Not described |
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Jan 2012 (estimated)
- Study startJan 2012
- Primary completionNov 2012 (estimated)
- Study completionDec 2012 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Arteriovenous FistulaStudies of the same condition, open and under way.
- More trials run by National Taiwan University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 150 participants (estimated)
Sponsor and investigators
- Lead sponsor
- National Taiwan University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, National Taiwan University Hospital, National Taiwan University Hospital
- Investigators
- Dong-Feng Yeih, Ph.D., Principal investigator, No.7, Chung Shan S. Rd., Zhongzheng Dist., Taipei City 100, Taiwan (R.O.C.)
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01512927
- Sponsor's protocol ID
- 201112015RIC
- Status last verified
- Jan 2012
- First submitted
- 15 Jan 2012
- Last updated
- 19 Jan 2012
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 Jan 2012. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Electronic Stethoscope and Computer-aided Diagnostic System in Detecting Arteriovenous Fistula (AVF) Stenosis
- ClinicalTrials.gov ID
- NCT01512927
- Acronym / sponsor ID
- 201112015RIC
- Conditions
- Arteriovenous Fistula
- Keywords
- electronic stethoscope, arteriovenous fistula, hemodialysis,
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 150 participants (estimated)
- Lead sponsor
- National Taiwan University HospitalUniversity, hospital or other
- Study start
- Jan 2012
- Primary completion
- Nov 2012 (estimated)
- Study completion
- Dec 2012 (estimated)
- First posted
- 19 Jan 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The incidence and prevalence of end-stage renal disease (ESRD) in Taiwan are both the highest worldwide from 2001 to 2008. In Taiwan, more than 90% of the ESRD patients are hemodialysis patients. Either arteriovenous fistula (AVF) or arteriovenous graft (AV graft) is essential for the vascular access of these patients. However, frequent AVF stenosis or thrombosis occurs in 10-30% hemodialytic patients, and the rates are even higher, around 30-70%, in those who has a past history of AVF/AV graft stenosis. Therefore, early detection of AVF stenosis is essential in caring for these hemodialysis patients in terms of medical economics and psychological impact. Unfortunately, angiographic study is expensive and invasive and needs contrast medium injection. The diagnostic accuracy of color duplex ultrasound in AVF stenosis remains satisfactory, but it is not always available when decreased AVF flow or an acute thrombotic event occurs. Continuous AVF/ AV graft flow monitoring by patient himself is a better option in terms of long-term care. Previous study indicated that stethoscope waveform analysis could be used as an alternative to diagnosis of vascular stenosis. Therefore, we aim to investigate AVF/ AV graft stenosis by using the electronic stethoscope (3M Littmann) for AVF sound recording, followed by software analysis by using waveform decomposition, principle component analysis (PCA) and sequential forward selection algorithm [xx]. Our study results will provide a new diagnostic option, which is low cost, non-invasive and self-monitoring, of AVF stenosis in ESRD patients.
Detailed description
Hemodialysis is a well-established method for removal of fluid and uremic toxins and prolonging survival in patients with end-stage renal disease (ESRD). The most common permanent vascular assesses are autogenous and non-autogenous arteriovenous (AV) fistula, referred as AV fistula and AV graft, respectively. In Taiwan, both incidence and prevalence of ESRD remain highest worldwide. However, frequent vascular stenosis/ thrombosis events occurred because of repeated needle punctures. These will exert a large economic burden to our society and psychological impacts on ESRD patients [1]. Therefore, it is essential to develop an easy and patient-centered method to monitor the flow status in either AV fistula or AV graft.
Physical examination and auscultation are simple monitoring methods to assess the vascular access. There were several signs reported to be associated vascular stenosis, such as prolonged bleeding, arm edema, and changes in pulse characteristics of the vascular access, but they need a high level of skill and experience from the operator, such as doctors and nurses [2].
Unfortunately, angiographic study is expensive and invasive and needs contrast medium injection. The diagnostic accuracy of color duplex ultrasound in AVF stenosis remains satisfactory, but it is not always available when decreased AVF flow or an acute thrombotic event occurs. Continuous AVF/ AV graft flow monitoring by patient himself is a better option in terms of long-term care. Previous study indicated that stethoscope waveform analysis could be used as an alternative to diagnosis of vascular stenosis. Previous acoustic studies indicated that increased sound intensity, extra sounds, and higher spectral energy infrequency domain, ranging between 300 Hz and 1000 Hz. These findings are associated with the change from laminar flow to turbulent flow downstream the site of vascular stenosis [3]. In addition, phonoangiography studies pointed out that the systolic peak of stenotic segment is higher and narrower in the time domain compared to non-stenotic segment Methods: This is an observational cohort study. We plan to recruit 150 eligible patients with ESRD under regular hemodialysis for at least one year in national Taiwan University Hospital.
- Data gathering A. The first group of patients (study group) will be recruited from hose referred to endovascular intervention, e.g. angioplasty, due to vascular access dysfunction (n=30). An electronic stethoscope (3M-Littmann) will be used to record digital sound signals at 5 points with 30 seconds each, including AV junction, proximal and distal to both needle puncture sites, respectively. All data will be transferred to a computer for further anlaysis.
- The second group (validation cohort) will be recruited from patients with regular hemodialysis (HD) and received angioplasty at National Taiwan University Hospital (n=120). Those patients who received angioplasty for AVF or AV graft stenosis will also received follow-up angiography 12 weeks after angioplasty. We will record digital AVF/AV graft sound signals as mentioned above. In addition, blood pressure and AVF/AVG venous pressure, heart rate will be recorded. Diameter stenosis of restenotic segment will also be recorded and a diameter stenosis of 50% is regarded as significant.
- Post-processing The proposed method is based on the analysis of the envelope of the sound signals. Before, calculating the envelope, all signals will be down-sampled to 2k Hz, followed by a linear-phase, finite impulse response low-pass filter. PCA will then be applied to analysis as described previously [1-4]. PCA (principal components analysis)
- Analysis Sensitivity, specificity and diagnostic accuracy will be calculated based on each diagnostic criteria or basal function. Area under ROC curve will be calculated based on each diagnostic criteria derived from PCA method.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| ESRD with regular hemodialysis | – | – |
Who may qualify
- Ages
- 20 to 90 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- 150
Key inclusion criteria (2 listed)
- Age is more than 20 year-old.
- End-stage renal disease with regular hemodialysis for more than one year
Key exclusion criteria (1 listed)
- 1. AVF/ AV graft is not located in upper arm.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Jan 2012.
Related trials for Arteriovenous Fistula
Recruiting
Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula
End Stage Renal Disease
Enrolling by invitationObservational study
Okami Medical ALPHA Registry
Arterial Bleed, Pulmonary Arteriovenous Malformation
Recruiting
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
Diabetes, End Stage Renal Disease
Not yet recruiting
A First-In-Man Study to Assess Safety and Efficacy of Ultra High Pressure PTA Balloon ULTRAVIOLET in Treating A-V Fistula Stenosis
Arterio-venous Fistula, Stenosis of Arteriovenous Dialysis Fistula
Active, not recruitingObservational study
Merit WRAPSODY™ Endoprosthesis for Treatment of Stenosis or Occlusion (WRAP)
Venous Stenosis, Venous Occlusion
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
DONG-FENG YEIH, Ph.D. contact
Dong-Feng Yeih, Ph.D. principal investigator
No.7, Chung Shan S. Rd., Zhongzheng Dist., Taipei City 100, Taiwan (R.O.C.)
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Arteriovenous Fistula, run by National Taiwan University Hospital at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 19 Jan 2012. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact DONG-FENG YEIH, Ph.D. (886-2-23123456 ext. 63738), or a site near the patient. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jan 2012.